The Latest About Avandia and Actos

| Aug 1, 2007

On July 30, 2007, a Food and Drug Administration (FDA) panel voted 22 to 1 to keep Avandia on the market, right after agreeing by a vote of 20 to 3 that Avandia does increase heart risks. Now the FDA will decide what kind of warning should appear on the Actos and Avandia labels. It has already called for a black box warning, the sternest possible, on Avandia.

In mid-June, the New England Journal of Medicine started the ruckus by reporting that Avandia increases risk of heart attack by 43 percent. Since then, Avandia prescriptions have fallen by about forty percent. However, reports to the FDA of Avandia-related heart attacks, deaths, and hospitalizations have multiplied.

In the month before the NEJM article, only five heart attacks associated with Avandia were reported by doctors: ninety have been reported since then. Reports of heart-related hospitalizations went from eleven to 126. It appears that doctors are now acutely aware of the possibility that Avandia is implicated in their patients' heart problems.

Another new meta-analysis, published in August's Diabetes Care, found that both Actos and Avandia double risk of heart failure. According to the study, one of every fifty patients who takes either Actos or Avandia for 26 months will suffer heart failure. The risk, which affects men and women equally, occurs even at low doses and in patients not taking insulin.

Furthermore, it strikes people without pre-existing risk factors for heart failure, the young as well as the elderly: a quarter of the heart failures occur in people under sixty years of age.

The research, which was conducted at Wake Forest University School of Medicine in North Carolina, analyzed data from trials and studies involving over 78,000 patients.

Heart failure (the inability of the heart to pump enough blood, possibly due to fluid retention) is already listed as a potential risk of thiazolidinediones, the class of drugs that includes Actos and Avandia. (It is different from heart attack, the side effect of Avandia discussed in the NEJM article.) However, the current labels warn only against use in patients with pre-existing serious heart failure and in combination with insulin. Given the Wake Forest findings, the researchers believe that those warnings are insufficient.

The Wake Forest researchers recommend seeing your doctor if you are taking or considering use of thiazolidinediones. Others, however, believe that the drugs' risk/benefit ratio doesn't warrant drastic measures like switching medicines. As Dr. Larry Deeb, president for medicine and science at the ADA, told, "The risk for heart failure with these drugs may be one in fifty, but if you can correctly identify who that person [at risk] is, you can safely treat the other 49 and not hurt anybody."

Yet another meta-analysis of Avandia was recently published, this time by the Cochrane Library. The study pooled data from eighteen randomized controlled trials of more than 8000 subjects, about half of whom took Avandia. Most of the trials lasted about six months; the longest covered four years.

The authors found that Avandia worked about as well to lower blood sugar as other oral anti-diabetic drugs. However, those taking Avandia gained weight, up to eleven pounds, and had twice the chance of developing edema (swelling) that can lead to heart failure. The largest reviewed trial, which involved 4000 patients, showed increased cardiovascular risk and increased risk of broken bones in women. The review authors advise a cautious approach to Avandia use, especially for people who have congestive heart failure and for thin women, who risk fracture.

Sources: International Herald Tribune; The Wall Street Journal;; Boston Globe; Diabetes Care, August 2007;; Cochrane Library, May 2007

Click Here To View Or Post Comments

Categories: Actos, Blood Sugar, Diabetes, Diabetes, Food, Heart Care & Heart Disease, Insulin, Pharmacy, Professional Issues, Type 2 Medications

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.